Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $4.7950 (-2.34%) ($4.7950 - $4.7950) on Thu. Nov. 18, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.65% (three month average) | RSI | 33 | Latest Price | $4.7950(-2.34%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -8.4% a day on average for past five trading days. | Weekly Trend | CGEN declines -11.6% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(73%) ARKG(70%) ARKK(69%) IWO(67%) IBUY(65%) | Factors Impacting CGEN price | CGEN will decline at least -2.325% in a week (0% probabilities). VIXM(-53%) VXX(-36%) UUP(-11%) TLT(-7%) UNG(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.325% (StdDev 4.65%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-12.67(-364.23%) | Resistance Level | $6.17 | 5 Day Moving Average | $5.23(-8.32%) | 10 Day Moving Average | $5.89(-18.59%) | 20 Day Moving Average | $6.17(-22.29%) | To recent high | -33.1% | To recent low | 0% | Market Cap | $397m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |